Pages that link to "Glossary:TAG-00111-Agr-chr"

The following pages link to Glossary:TAG-00111-Agr-chr:

Displaying 29 items.

• Glossary (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - contract research organization (CRO) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 9 (← links)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III 2. ; 7. (← links)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 2 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.52 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 1.4 (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (4) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.5 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Agreement (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.6 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.14-001 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - contract (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.11 (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 6.9 (← links)
• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 33 (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 9 (← links)
• Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1121-3-1 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (k)-(l) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (5) (← links)
• Reference:GBR Medicines and Medical Devices Act 2021 21-Feb-2021 Chapter 2 Article 8 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.5 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - Introduction (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.110 (b) (← links)
• Reference:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 3.1 (← links)
• Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D Who should notify (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.14-002 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 16 (← links)
• Reference:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.5 (← links)